Comprehensive Tech Platform's Data Collection
and Transmission to Inform Public Health Officials, Accelerate Care
Delivery in Pharmacy Settings
MADISON,
Wis., Feb. 28, 2024 /PRNewswire/ -- Workflow
Services, a comprehensive and automated platform that solves
point-of-care clinical service delivery for pharmacies, marked a
major milestone in its partnership with the FDA in its
groundbreaking Diagnostic Data Program.
In the 100 days since the FDA selected Workflow Services as its
partner to collect data from point-of-care tests administered
across U.S. pharmacies, Workflow Services has grown the footprint
of users on its platform, built partnerships with industry trade
organizations and test manufacturers, and added talent to its team
to accelerate the mission of making pharmacists a key player in
local healthcare delivery.
"The retail pharmacy setting is rapidly evolving. It's moving in
ways and at a pace that it never really has," said Kevin Houlihan, CEO of Workflow Services and
ImageMover. "The FDA's Diagnostic Data Program signals that
point-of-care testing in non-traditional settings is here to stay
and will only continue to grow. It's why our team has been moving
fast to expand our footprint, optimize our solution, and help
pharmacies accelerate their plans to put healthcare and wellness
services at the forefront of their retail operations."
Fully realized, the FDA Program's aim of de-identified data
collection and transmission will aid federal and state public
health leaders in making evidence-based decisions from a regulatory
as well as population health standpoint. Access to diagnostic
testing data provides early, and actionable information related to
viruses' location and spread—vital information that can empower
proactive, targeted intervention to minimize transmission and
suppress outbreaks.
Earlier this year, Workflow Services announced a set of new
leadership positions to add expertise to a team rapidly growing its
user base and expanding its capacity to collect real-world data for
analysis by healthcare experts at the FDA.
"We are growing and adding team members with a wealth of
industry knowledge, enabling us to be a stronger, more receptive,
and agile partner to our pharmacy customers," said Elise Miller Hoffman, COO of Workflow Services
and ImageMover.
The FDA's Diagnostic Data Program is the first of its kind. More
information is available here.
Learn more about Workflow Services' partnership with the
FDA, where you can sign up for regular updates.
About Workflow Services
Workflow Services is a healthcare software developed by
ImageMoverMD, Inc. that innovates point-of-care medical workflow
solutions for healthcare professionals and patients. The company
securely captures and integrates medical data to simplify
communication and enhance patient care. ImageMoverMD, Inc. was
founded in 2013 to design and deliver a secure solution for
managing images at the point-of-care. In 2023, the Food and Drug
Administration (FDA) selected Workflow Services as a partner in its
Diagnostic Data Program, launched to collect data from
point-of-care tests administered nationally in pharmacy settings.
To learn more visit LinkedIn or www.workflowservices.com
Media Contact:
John Flaherty
373717@email4pr.com
(773) 799-8200
View original
content:https://www.prnewswire.com/news-releases/workflow-services-momentum-100-days-into-fdas-point-of-care-delivery-initiative-at-pharmacies-302074569.html
SOURCE Workflow Services